Charles McWherter - Jan 24, 2024 Form 4 Insider Report for CymaBay Therapeutics, Inc. (CBAY)

Role
President of R&D
Signature
/s/ Paul Quinlan, as attorney-in-fact for Charles McWherter
Stock symbol
CBAY
Transactions as of
Jan 24, 2024
Transactions value $
$0
Form type
4
Date filed
1/26/2024, 06:29 PM
Previous filing
Jan 22, 2024
Next filing
Mar 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CBAY Common Stock Award $0 +31.9K +212.92% $0.00 46.9K Jan 24, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CBAY Employee Stock Option (right to buy) Award $0 +119K $0.00 119K Jan 24, 2024 Common Stock 119K $22.85 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The grant shall vest as to 1/4 of the shares on each of January 15, 2025, January 15, 2026, January 15, 2027 and January 15, 2028.
F2 The option grant vests as to 1/48 of the underlying shares monthly from January 1, 2024.